Evolution of postoperative care: marked reduction of opioid consumption when ERAC pathway added to wound soaker therapy for cesarean delivery

References

• Jeong O, Ryu S, Park Y. Postoperative functional recovery after gastrectomy in patients undergoing enhanced recovery after surgery: a prospective assessment using standard discharge criteria. Medicine. 2016;95(14):e3140.
   PubMed Web of Science ®Google Scholar
• Wong J, Tong D, De Silva Y, et al. Development of the functional recovery index for ambulatory surgery and anesthesia. Anesthesiology. 2009;110(3):596–602.
   PubMed Web of Science ®Google Scholar
• Bollag L, Nelson G. Enhanced recovery after cesarean (ERAC) – beyond the pain scores. Int J Obstet Anesth. 2020;43:36–38.
   PubMed Web of Science ®Google Scholar
• Alam A, Gomes T, Zheng H, et al. Long-term analgesic use after low-risk surgery: a retrospective cohort study. Arch Intern Med. 2012;172(5):425–430.
   PubMedGoogle Scholar
• Bateman BT, Franklin JM, Bykov K, et al. Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naïve women. Am J Obstet Gynecol. 2016;215(3):353.
   PubMed Web of Science ®Google Scholar
• Eisenach JC, Pan PH, Smiley R, et al. Severity of acute pain after childbirth, but not type of delivery, predicts persistent pain and postpartum depression. Pain. 2008;140(1):87–94.
   PubMed Web of Science ®Google Scholar
• Jin J, Peng L, Chen Q, et al. Prevalence and risk factors for chronic pain following cesarean section: a prospective study. BMC Anesthesiol. 2016;16(1):99.
   PubMed Web of Science ®Google Scholar
• Metz TD, Rovner P, Hoffman MC, et al. Maternal deaths from suicide and overdose in Colorado, 2004-2012. Obstet Gynecol. 2016;128(6):1233–1240.
   PubMed Web of Science ®Google Scholar
• Drug overdose was the 2nd leading cause of the death in CO 2014-2016. https://www.colorado.gov/pacific/cdphe/maternal-mortality.
   Google Scholar
• Zaretsky M, Wood C, Nivens T, et al. Continuous local bupivacaine wound infusion with neuraxial morphine reduces opioid consumption after cesarean delivery. J Matern Fetal Neonatal Med. 2019;32(23):3895–3902.
   PubMed Web of Science ®Google Scholar
• Bollag L, Lim G, Sultan P, et al. Society for obstetric anesthesia and perinatology: consensus statement and recommendations for enhanced recovery after cesarean. Anesth Analg. 2021;132(5):1362–1377.
   PubMed Web of Science ®Google Scholar
• Hoenig JM, Heisey DM. The abuse of power: the pervasive fallacy of power calculations for data analysis. The American Statistician. 2001;55(1):19–24.
   Web of Science ®Google Scholar
• Goodman SN, Berlin JA. The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results. Ann Intern Med. 1994;121(3):200–206.
   PubMed Web of Science ®Google Scholar
• OʼNeill P, Duarte F, Ribeiro I, et al. Ropivacaine continuous wound infusion versus epidural morphine for postoperative analgesia after cesarean delivery: a randomized controlled trial. Anesth Analg. 2012;114(1):179–185.
   PubMed Web of Science ®Google Scholar
• Kainu JP, Sarvela J, Halonen P, et al. Continuous wound infusion with ropivacaine fails to provide adequate analgesia after cesarean section. Int J Obstet Anesth. 2012;21(2):119–124.
   PubMed Web of Science ®Google Scholar
• Rackelboom T, Le Strat S, Silvera S, et al. Improving continuous wound infusion effectiveness for postoperative analgesia after cesarean delivery: a randomized controlled trial. Obstet Gynecol. 2010;116(4):893–900.
   PubMed Web of Science ®Google Scholar
• Rosetti J, Francotte J, Noel E, et al. Continuous ropivacaine subfascial wound infusion after cesarean delivery in pain management: a prospective randomized controlled double-blind study. Int J Gynaecol Obstet. 2021;154(1):79–84.
   PubMed Web of Science ®Google Scholar
• Jolly C, Jathières F, Keïta H, et al. Cesarean analgesia using levobupivacaine continuous wound infiltration: a randomized trial. Eur J Obstet Gynecol Reprod Biol. 2015;194:125–130.
   PubMed Web of Science ®Google Scholar
• Gómez-Ríos MÁ, Codesido-Barreiro P, Seco-Vilariño C, et al. Wound infusion of 0.35% levobupivacaine reduces mechanical secondary hyperalgesia and opioid consumption after cesarean delivery: a prospective, randomized, Triple-Blind, Placebo-Controlled trial. Anesth Analg. 2022;134(4):791–801.
   PubMed Web of Science ®Google Scholar
• Lester S, Kim B, Tubinis M, et al. Impact of an enhanced recovery program for cesarean delivery on postoperative opioid use. Int J Obstet Anesth. 2020;43:47–55.
   PubMed Web of Science ®Google Scholar
• Shinnick JK, Ruhotina M, Has P, et al. Enhanced recovery after surgery for cesarean delivery decreases length of hospital stay and opioid consumption: a quality improvement initiative. Am J Perinatol. 2021;38(S 01):e215–e223.
   PubMedGoogle Scholar
• Mullman L, Hilden P, Goral J, et al. Improved outcomes with an enhanced recovery approach to cesarean delivery. Obstet Gynecol. 2020;136(4):685–691.
   PubMed Web of Science ®Google Scholar
• Kleiman AM, Chisholm CA, Dixon AJ, et al. Evaluation of the impact of enhanced recovery after surgery protocol implementation on maternal outcomes following elective cesarean delivery. Int J Obstet Anesth. 2020;43:39–46.
   PubMed Web of Science ®Google Scholar